Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BROCKTON HOSPITAL, INC.

NPI: 1063431286 · BROCKTON, MA 02302 · General Acute Care Hospital · NPI assigned 07/19/2006

$160.74M
Total Medicaid Paid
3,609,047
Total Claims
3,063,697
Beneficiaries
543
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAFFEY, ROBERT (CEO)
NPI Enumeration Date07/19/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 594,734 $25.63M
2019 597,939 $22.90M
2020 506,954 $19.09M
2021 644,072 $26.51M
2022 689,272 $31.64M
2023 278,356 $20.03M
2024 297,720 $14.95M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 105,443 94,774 $15.48M
99283 Emergency department visit for the evaluation and management, moderate severity 90,498 85,290 $10.89M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 72,956 65,954 $10.80M
99284 Emergency department visit for the evaluation and management, high severity 84,277 79,962 $10.04M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 68,587 62,985 $9.82M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 58,094 52,943 $9.43M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 106,194 29,465 $6.65M
96361 Intravenous infusion, hydration; each additional hour 19,574 15,831 $6.54M
G0378 Hospital observation service, per hour 23,509 13,322 $3.12M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 108,682 84,379 $2.96M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15,612 12,821 $2.94M
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 16,122 15,572 $2.16M
74177 Computed tomography, abdomen and pelvis; with contrast material 12,486 11,760 $2.15M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 14,228 10,995 $2.08M
59025 Fetal non-stress test 7,978 5,442 $2.02M
99282 Emergency department visit for the evaluation and management, low to moderate severity 17,192 16,605 $1.75M
70450 Computed tomography, head or brain; without contrast material 12,970 11,886 $1.74M
76830 Ultrasound, transvaginal 14,338 13,876 $1.43M
77063 Screening digital breast tomosynthesis, bilateral 18,383 17,976 $1.38M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 28,090 26,122 $1.35M
76801 9,799 8,433 $1.33M
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1,072 1,054 $1.30M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1,078 1,047 $1.18M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 26,179 22,290 $1.11M
97161 15,346 14,333 $1.10M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 7,235 6,647 $1.09M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 7,406 6,457 $1.05M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,422 1,352 $1.02M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 5,494 3,117 $994K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 6,407 5,841 $969K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 7,893 7,607 $959K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 34,680 32,929 $929K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 33,616 31,928 $895K
76705 Ultrasound, abdominal, real time with image documentation; limited 7,299 6,943 $850K
76819 Fetal biophysical profile; without non-stress testing 12,464 8,563 $810K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4,444 4,102 $805K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 40,954 13,167 $805K
71275 Computed tomographic angiography, chest, with contrast material 3,571 3,321 $767K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 5,601 4,326 $738K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 10,022 7,400 $718K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,707 4,705 $706K
70551 Magnetic resonance imaging, brain; without contrast material 2,503 2,345 $689K
93971 3,045 2,842 $662K
71046 Radiologic examination, chest; 2 views 29,999 27,869 $657K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 137,266 113,859 $654K
93975 4,772 4,465 $650K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1,704 1,554 $647K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,807 3,578 $644K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1,992 1,937 $609K
76642 5,732 5,542 $607K
81513 7,350 7,007 $604K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,112 4,101 $598K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 2,586 2,527 $573K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 16,226 5,771 $495K
76813 3,094 2,987 $491K
77067 Screening mammography, bilateral, including computer-aided detection 19,361 18,939 $484K
96367 2,873 1,964 $473K
76536 3,729 3,636 $457K
73562 12,205 11,476 $441K
76770 2,846 2,712 $441K
84443 Thyroid stimulating hormone (TSH) 47,982 45,028 $434K
87428 7,889 7,622 $430K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,774 2,763 $418K
83036 Hemoglobin; glycosylated (A1C) 74,429 70,502 $412K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 23,274 15,991 $396K
76700 Ultrasound, abdominal, real time with image documentation; complete 2,109 2,056 $373K
88305 Level IV - Surgical pathology, gross and microscopic examination 10,501 9,913 $353K
71260 Computed tomography, thorax, diagnostic; with contrast material 3,501 3,299 $339K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 4,417 2,626 $337K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 2,577 2,543 $323K
94060 3,434 3,244 $316K
80053 Comprehensive metabolic panel 79,396 71,222 $307K
80048 Basic metabolic panel (calcium, ionized) 96,526 77,299 $304K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 18,901 18,010 $298K
12001 1,774 1,724 $298K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 21,050 13,970 $296K
73030 8,964 8,310 $293K
45380 Colonoscopy, flexible; with biopsy, single or multiple 310 296 $285K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 30,266 26,055 $280K
73630 8,886 8,197 $273K
93017 2,766 2,520 $266K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,005 1,912 $265K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 4,770 3,926 $262K
80050 General health panel 15,070 14,999 $255K
73130 7,536 6,827 $247K
82805 7,866 6,469 $247K
99218 5,274 3,742 $245K
73221 877 856 $239K
85027 51,362 46,235 $238K
71250 3,349 3,191 $234K
87390 13,575 13,286 $231K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 12,811 12,267 $226K
80061 Lipid panel 60,865 58,691 $225K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 8,928 8,805 $222K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 532 519 $221K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 1,777 1,761 $221K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 56,316 48,509 $216K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 7,457 7,116 $213K
87481 7,444 7,103 $213K
81025 37,537 34,863 $212K
84484 26,325 21,112 $211K
96375 Therapeutic injection; each additional sequential IV push 25,558 19,938 $208K
84702 16,247 13,126 $208K
87086 Culture, bacterial; quantitative colony count, urine 33,257 30,259 $207K
10060 1,280 1,220 $203K
95886 672 588 $202K
77066 Tomosynthesis, mammo 2,773 2,688 $200K
88142 12,103 11,984 $196K
73610 6,677 6,193 $195K
J1756 Injection, iron sucrose, 1 mg 2,470 952 $194K
99220 1,379 1,279 $191K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 16,122 15,493 $185K
73110 5,013 4,564 $179K
87480 10,630 9,892 $172K
87510 10,627 9,890 $171K
87660 10,620 9,885 $171K
90715 7,468 7,259 $169K
83880 9,961 8,393 $164K
90686 10,967 10,577 $162K
73502 5,190 4,847 $154K
86803 14,639 14,208 $153K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,599 2,597 $148K
72100 4,463 4,289 $144K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1,022 991 $143K
77080 2,295 2,243 $143K
97165 1,954 1,708 $142K
86780 12,649 12,316 $136K
94727 3,102 2,936 $136K
90460 Immunization administration through 18 years of age via any route, first or only component 14,923 14,805 $135K
71271 2,480 2,430 $130K
82728 14,871 13,703 $128K
72110 3,325 3,173 $126K
83690 24,424 21,591 $120K
ATP08 18,291 16,036 $119K
83735 29,512 20,178 $119K
76820 3,215 2,360 $116K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1,501 1,483 $115K
81001 49,046 44,448 $113K
82607 12,841 12,019 $113K
72125 Computed tomography, cervical spine; without contrast material 4,715 4,359 $112K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 5,026 4,264 $108K
74183 275 274 $107K
62323 172 170 $107K
ATP15 12,344 10,463 $106K
93270 9,502 4,317 $105K
12011 634 626 $104K
72141 446 428 $102K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 2,593 2,588 $97K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 290 287 $95K
86618 7,112 3,919 $93K
97802 1,020 1,017 $91K
80076 37,664 32,956 $90K
77065 Tomosynthesis, mammo 1,087 1,069 $85K
94618 846 786 $83K
74018 2,169 2,015 $82K
87340 9,846 9,548 $81K
83970 3,678 3,493 $79K
97803 900 853 $75K
94729 3,177 3,005 $75K
85379 10,810 9,970 $72K
73140 2,140 2,006 $69K
G0297 Low dose ct scan (ldct) for lung cancer screening 775 734 $67K
85610 27,703 19,746 $67K
93970 333 309 $66K
82746 7,818 7,240 $66K
73080 2,096 1,984 $65K
88342 2,222 2,059 $65K
86850 10,287 9,457 $64K
87186 10,683 9,881 $64K
87081 11,414 10,987 $64K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 598 580 $64K
29125 683 667 $64K
87653 2,121 2,092 $63K
83605 8,692 6,940 $63K
82570 19,695 18,545 $61K
83540 14,874 13,688 $61K
ATP14 10,869 9,849 $59K
84439 10,466 9,871 $58K
12002 379 365 $58K
87631 521 507 $57K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 3,435 1,613 $55K
83550 10,051 9,170 $55K
81003 33,231 31,226 $54K
86762 4,363 4,227 $54K
82043 17,491 16,690 $54K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7,165 6,133 $53K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 957 909 $53K
76882 484 459 $52K
96415 343 222 $51K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 153 144 $51K
83721 9,897 9,385 $50K
80074 1,310 1,280 $49K
86787 4,151 4,043 $49K
84146 3,298 3,163 $48K
99215 Prolong outpt/office vis 213 209 $48K
72050 1,033 1,012 $47K
86003 1,026 543 $47K
82784 6,738 3,631 $46K
99217 835 795 $46K
73564 732 710 $46K
77002 247 235 $44K
71045 Radiologic examination, chest; single view 10,693 9,527 $44K
87420 4,007 3,868 $43K
87040 4,423 3,664 $43K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 4,591 4,445 $42K
70491 313 292 $40K
J2469 Injection, palonosetron hcl, 25 mcg 405 200 $39K
97162 533 506 $39K
86334 3,160 2,888 $38K
86140 10,669 9,558 $37K
87522 Neg quan hep c or qual rna 1,043 1,016 $37K
90677 858 833 $37K
72040 700 689 $37K
S9485 Crisis intervention mental health services, per diem 94 52 $37K
86706 4,545 4,363 $36K
86704 4,012 3,846 $35K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 436 415 $35K
84100 21,185 13,850 $34K
70486 779 742 $34K
83001 2,154 2,115 $33K
84145 5,104 3,947 $33K
88304 2,366 2,243 $33K
86696 1,297 1,256 $33K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 664 334 $32K
84403 1,665 1,595 $31K
90750 555 550 $31K
93296 1,086 1,011 $31K
86900 12,052 10,993 $31K
83021 1,949 1,905 $31K
76886 209 204 $31K
87088 5,445 5,114 $31K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 315 314 $30K
84703 4,906 4,620 $29K
92551 289 287 $29K
Q3014 Telehealth originating site facility fee 12,457 11,255 $29K
82962 13,915 8,634 $28K
86901 11,991 10,932 $28K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 1,881 1,790 $28K
82670 1,103 1,086 $28K
84425 1,714 1,662 $27K
J1650 Injection, enoxaparin sodium, 10 mg 3,798 1,769 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 704 657 $27K
85652 14,417 13,076 $26K
96376 8,276 4,956 $26K
87070 4,233 3,872 $25K
86235 674 346 $25K
85730 6,357 5,604 $25K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 713 707 $25K
84165 3,339 3,051 $24K
86038 2,769 2,604 $24K
83516 1,813 1,244 $23K
86708 2,426 2,359 $23K
86480 516 493 $23K
ATP17 8,491 7,669 $22K
73590 1,256 1,162 $22K
97035 322 138 $22K
86695 1,299 1,256 $22K
ATP09 3,382 2,543 $22K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 11,627 8,863 $22K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 23,316 18,708 $22K
J3010 Injection, fentanyl citrate, 0.1 mg 16,932 10,808 $22K
87147 5,040 4,745 $22K
87077 4,671 4,324 $21K
84402 921 903 $20K
J2704 Injection, propofol, 10 mg 17,874 13,497 $20K
J2250 Injection, midazolam hydrochloride, per 1 mg 7,032 5,946 $20K
84480 2,107 1,995 $19K
J1885 Injection, ketorolac tromethamine, per 15 mg 22,368 15,926 $19K
36415 Collection of venous blood by venipuncture 48,431 39,405 $19K
72197 48 48 $18K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 841 696 $18K
90472 Immunization administration, each additional vaccine (list separately) 1,936 1,888 $18K
99173 431 430 $18K
G0008 Administration of influenza virus vaccine 4,259 4,053 $17K
80179 2,926 2,629 $17K
ATP16 1,935 1,495 $17K
0240U 412 395 $17K
90670 1,782 1,765 $16K
99381 103 102 $16K
J1439 Injection, ferric carboxymaltose, 1 mg 17 14 $16K
76870 166 160 $16K
72072 442 434 $16K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,989 4,333 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg 20,666 15,913 $15K
83002 862 860 $15K
82950 3,274 3,247 $14K
90662 1,461 1,338 $14K
93299 466 432 $14K
80143 2,789 2,485 $14K
82565 9,521 8,850 $13K
80171 1,489 1,445 $13K
87205 4,204 3,807 $13K
84466 1,182 1,161 $13K
87338 1,144 1,131 $13K
70496 115 104 $13K
J0690 Injection, cefazolin sodium, 500 mg 5,535 4,486 $12K
19083 12 12 $12K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 935 777 $11K
73090 607 566 $11K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,912 2,047 $11K
85045 4,234 3,887 $11K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 7,366 6,010 $10K
88300 288 268 $10K
84460 7,713 7,113 $10K
84550 5,253 4,681 $10K
20610 45 42 $9K
83883 1,236 791 $9K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 327 324 $9K
84153 1,130 1,050 $9K
82550 5,296 4,680 $9K
82747 609 604 $9K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 171 165 $9K
90746 314 313 $9K
71101 385 368 $9K
86709 911 905 $9K
90651 866 863 $9K
90732 361 361 $9K
J1030 Injection, methylprednisolone acetate, 40 mg 3,638 3,375 $9K
90656 787 783 $9K
83010 1,027 956 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg 9,836 7,055 $8K
84450 7,033 6,463 $8K
ATP02 2,496 2,116 $8K
86765 626 620 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 282 275 $8K
84520 7,205 6,687 $8K
92552 50 50 $8K
87899 734 406 $8K
86735 598 592 $8K
76942 27 26 $7K
90620 446 442 $7K
97014 78 27 $7K
83615 3,790 3,374 $7K
86160 532 367 $7K
86666 507 264 $7K
84156 2,368 1,948 $7K
88313 393 368 $7K
84132 4,616 4,251 $7K
87046 841 458 $6K
86317 372 363 $6K
74019 558 507 $6K
95909 35 35 $6K
80164 1,438 1,299 $6K
84255 245 244 $6K
84155 2,990 2,730 $6K
85018 2,845 2,586 $5K
82247 2,788 1,962 $5K
82150 998 959 $5K
86617 351 187 $5K
82465 1,136 1,105 $5K
J2785 Injection, regadenoson, 0.1 mg 268 242 $5K
ATP03 4,868 4,488 $5K
86430 1,018 986 $5K
90694 514 511 $5K
84144 241 207 $4K
82525 421 412 $4K
86376 343 337 $4K
86039 500 472 $4K
ATP05 856 766 $4K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 1,252 1,113 $4K
87045 470 444 $4K
82172 267 259 $4K
84630 395 391 $4K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 23 13 $4K
85014 2,227 1,984 $4K
82947 1,960 1,851 $4K
88312 54 54 $4K
82785 271 263 $4K
20552 13 13 $4K
90716 446 443 $4K
84295 1,722 1,624 $4K
82627 172 172 $4K
87015 745 686 $4K
93225 40 39 $4K
82274 228 226 $3K
J1644 Injection, heparin sodium, per 1000 units 3,284 1,287 $3K
93226 38 37 $3K
90707 494 492 $3K
J2060 Injection, lorazepam, 2 mg 5,685 3,915 $3K
86255 107 54 $3K
J2270 Injection, morphine sulfate, up to 10 mg 7,340 4,402 $3K
86753 286 148 $3K
86200 215 213 $3K
73560 55 54 $3K
ATP07 741 675 $3K
86580 249 237 $2K
97760 48 37 $2K
90653 300 300 $2K
82140 452 369 $2K
82310 968 952 $2K
87625 68 68 $2K
0071A 51 51 $2K
82040 1,003 962 $2K
73552 65 62 $2K
99224 74 39 $2K
97018 29 26 $2K
94760 5,227 4,699 $2K
82652 63 62 $2K
88311 70 67 $2K
87329 200 190 $2K
85007 985 794 $2K
90688 51 51 $2K
0072A 40 40 $2K
93298 84 76 $2K
87328 186 177 $2K
72131 41 39 $2K
82977 647 628 $2K
82668 147 136 $2K
99188 46 46 $2K
82378 115 90 $2K
84481 102 102 $1K
72081 27 27 $1K
J3411 Injection, thiamine hcl, 100 mg 25 12 $1K
87181 581 542 $1K
83520 127 122 $1K
86308 307 294 $1K
82533 98 94 $1K
86225 128 122 $1K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 14 14 $1K
82077 271 241 $1K
95913 12 12 $1K
87493 55 51 $1K
83986 641 613 $1K
ATP18 670 560 $1K
J1040 Injection, methylprednisolone acetate, 80 mg 278 250 $1K
99234 12 12 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 2,142 1,670 $1K
G0009 Administration of pneumococcal vaccine 513 494 $984.24
J2765 Injection, metoclopramide hcl, up to 10 mg 6,143 5,335 $977.22
ATP10 435 382 $974.06
Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml 1,297 1,139 $950.16
92083 28 28 $939.49
69209 71 71 $939.26
82951 77 74 $926.93
73060 44 40 $923.09
83525 81 81 $912.65
92133 25 25 $871.91
ATP11 412 351 $763.28
86880 216 206 $721.89
74220 12 12 $695.18
0001A 15 15 $688.20
83498 24 24 $672.24
82248 1,515 1,119 $656.27
93246 238 223 $650.05
80051 209 202 $617.24
ATP13 250 237 $598.95
84311 413 397 $538.80
J1170 Injection, hydromorphone, up to 4 mg 266 182 $502.41
73523 12 12 $502.41
86431 92 91 $494.14
80178 196 173 $483.16
86769 12 12 $469.90
J3475 Injection, magnesium sulfate, per 500 mg 924 577 $466.53
74174 12 12 $462.72
82340 106 103 $453.68
93242 206 203 $447.19
90734 134 133 $423.61
70498 91 79 $417.36
90461 219 213 $410.95
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 685 671 $392.85
87184 123 110 $384.47
86800 27 27 $381.36
ATP04 113 104 $362.90
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 616 597 $350.61
87255 12 12 $347.79
80069 110 102 $325.47
82330 31 29 $319.02
ATP23 32 26 $314.73
70360 12 12 $302.52
90696 245 245 $298.00
J1630 Injection, haloperidol, up to 5 mg 1,137 817 $286.23
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 535 478 $278.23
88173 13 13 $261.56
87425 22 22 $240.68
90633 879 876 $210.71
90632 13 12 $203.60
76376 1,639 1,599 $202.32
87324 33 27 $192.42
80177 46 43 $191.38
83718 28 27 $187.96
S9083 Global fee urgent care centers 292 285 $179.72
81050 65 65 $175.98
96417 34 26 $172.54
J3370 Injection, vancomycin hcl, 500 mg 1,164 484 $169.27
ATP06 69 60 $105.04
82948 23 21 $102.70
88112 18 12 $79.38
80156 13 12 $75.15
85049 12 12 $51.79
82952 14 14 $50.12
J0713 Injection, ceftazidime, per 500 mg 173 114 $48.15
84075 13 12 $43.90
15853 14 14 $39.24
82272 14 12 $38.56
J2550 Injection, promethazine hcl, up to 50 mg 153 134 $27.02
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 77 29 $27.00
82270 13 12 $26.88
90710 76 76 $19.06
J2795 Injection, ropivacaine hydrochloride, 1 mg 68 64 $18.13
90713 14 14 $14.16
J1815 Injection, insulin, per 5 units 59 25 $8.33
C9113 Injection, pantoprazole sodium, per vial 2,185 1,446 $8.15
96368 33 25 $0.00
C1769 Guide wire 225 183 $0.00
90680 41 40 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 204 195 $0.00
90697 336 336 $0.00
90723 650 649 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 45 42 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 93 79 $0.00
80320 115 109 $0.00
94761 393 360 $0.00
J0515 Injection, benztropine mesylate, per 1 mg 113 68 $0.00
A9585 Injection, gadobutrol, 0.1 ml 23 22 $0.00
A4648 Tissue marker, implantable, any type, each 12 12 $0.00
90744 16 16 $0.00
84478 21 13 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 85 78 $0.00
J3360 Injection, diazepam, up to 5 mg 159 96 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 82 63 $0.00
80329 65 61 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 15 12 $0.00
91307 21 16 $0.00
J1790 Injection, droperidol, up to 5 mg 15 14 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 16 16 $0.00
90648 1,041 1,037 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 511 467 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 3,616 2,916 $0.00
99053 15 14 $0.00
99221 28 27 $0.00
90700 335 332 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 76 75 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 662 590 $0.00
90681 310 310 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 70 44 $0.00
90649 13 12 $0.00
90685 32 32 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 199 107 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 21 13 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 29 29 $0.00
J1953 Injection, levetiracetam, 10 mg 20 13 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 14 12 $0.00
87563 18 15 $0.00